Home
    Disclaimer
    ← Back to bk-MDA
    bk-MDA molecular structure

    bk-MDA Stats & Data

    Stimulant
    NPS DataHub
    MW193.2
    FormulaC10H11NO3
    CAS80535-73-5
    IUPAC(2R)-2-amino-1-(1,3-benzodioxol-5-yl)propan-1-one
    SMILESCC(N)C(=O)c1ccc2OCOc2c1
    InChIKeyXDEZOLVDJWWXRG-ZCFIWIBFSA-N
    Phenethylamines; Cathinones; 2020/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2021/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2022/1. Von 2-Phenethylamin abgeleitete Verbindungen
    Psychoactive Class Stimulant

    Pharmacology

    DrugBank

    Description

    BK-MDA has been used in trials studying the treatment of Bladder Exstrophy and Urinary Incontinence.

    Effect Profile

    Curated
    Stimulant 6.5

    Strong euphoria and anxiety/jitters with moderate focus and stimulation

    Stimulation / Energy×3
    6
    Euphoria / Mood Lift×2
    10
    Focus / Productivity×2
    7
    Anxiety / Jitters×1
    10
    Based on reports from:
    Erowid Experience Reports PsychonautWiki bk-MDA

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1d Half tolerance 10d Baseline ~18d
    ← Back to bk-MDA